These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17285459)

  • 41. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
    Heitz F; Harter P; Ewald-Riegler N; Papsdorf M; Kommoss S; du Bois A
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.
    Cho LC; Choy H
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):29-39. PubMed ID: 15255165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stilbenes and bibenzyls with potential anticancer or chemopreventive activity.
    Orsini F; Verotta L
    Adv Exp Med Biol; 1999; 472():169-86. PubMed ID: 10736625
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuro-oncology: clinical and molecular predictive factors.
    Vecht CJ
    Lancet Neurol; 2009 Jan; 8(1):17-9. PubMed ID: 19081507
    [No Abstract]   [Full Text] [Related]  

  • 45. [Current problems of early phase clinical trials for new anticancer agents in Japan].
    Nakagawa K; Fukuoka M
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):925-9. PubMed ID: 10897223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biocatalytic production of acyclic bis[bibenzyls] from dihydroresveratrol by crude Momordica charantia peroxidase.
    Xie CF; Yuan HQ; Qu JB; Xing J; Lü BB; Wang XN; Ji M; Lou HX
    Chem Biodivers; 2009 Aug; 6(8):1193-201. PubMed ID: 19697337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical status and optimal use of topotecan.
    Takimoto CH; Arbuck SG
    Oncology (Williston Park); 1997 Nov; 11(11):1635-46; discussion 1649-51, 1655-7. PubMed ID: 9394364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New cytotoxics in oncology. From the editor.
    Bates SE
    Clin Cancer Res; 2008 Mar; 14(6):1609. PubMed ID: 18437723
    [No Abstract]   [Full Text] [Related]  

  • 49. PARP inhibitors in cancer: moving beyond BRCA.
    Telli ML
    Lancet Oncol; 2011 Sep; 12(9):827-8. PubMed ID: 21862406
    [No Abstract]   [Full Text] [Related]  

  • 50. [The current potentials and outlook for drug therapy in oncology].
    Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
    Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma.
    Daniel RA; Rozanska AL; Thomas HD; Mulligan EA; Drew Y; Castelbuono DJ; Hostomsky Z; Plummer ER; Boddy AV; Tweddle DA; Curtin NJ; Clifford SC
    Clin Cancer Res; 2009 Feb; 15(4):1241-9. PubMed ID: 19174487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cancer therapy by PARP inhibitors].
    Seimiya H
    Nihon Rinsho; 2015 Aug; 73(8):1330-5. PubMed ID: 26281686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.
    Thomas C; Ji Y; Lodhi N; Kotova E; Pinnola AD; Golovine K; Makhov P; Pechenkina K; Kolenko V; Tulin AV
    EBioMedicine; 2016 Nov; 13():90-98. PubMed ID: 27727003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new philosophy in breast cancer therapy.
    Bonadonna G
    Cancer J Sci Am; 1998; 4(4):224-5. PubMed ID: 9689979
    [No Abstract]   [Full Text] [Related]  

  • 55. Molecular imaging: what picture does it paint for future oncology?
    Price P; Jones T
    Drug Discov Today; 2002 Jul; 7(14):741-3. PubMed ID: 12547021
    [No Abstract]   [Full Text] [Related]  

  • 56. [In process].
    Jungmayr P
    Med Monatsschr Pharm; 2017 Mar; 40(3):127-9. PubMed ID: 29952484
    [No Abstract]   [Full Text] [Related]  

  • 57. Translational research in oncology comes timely.
    Chow LW; Toi M
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S263. PubMed ID: 16507388
    [No Abstract]   [Full Text] [Related]  

  • 58. [Introduction].
    Koch M; Monneret C
    Ann Pharm Fr; 2005 Jan; 63(1):4-6. PubMed ID: 15803093
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuro-oncology 1999.
    Rosenberg RN
    Arch Neurol; 1999 Apr; 56(4):397-8. PubMed ID: 10199325
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug shortages in oncology.
    McBride A; Johnson PE
    Am J Health Syst Pharm; 2012 Jul; 69(14):1190. PubMed ID: 22761069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.